Critically, we are the first to systematically reveal NLRP5’s potent oncogenic function in HCC, demonstrating its role through the regulation of the p53 signaling pathway to impact cell cycle control and apoptosis. Here, NLRP5 is linked to hepatocellular carcinoma.